{"id":"W4405181643","doi":"10.1158/1538-8514.cancerchem24-pr001","title":"Abstract PR001: Discovery of Etrumadenant, a first-in-class dual A2a and A2b adenosine receptor antagonist for cancer immunotherapy","year":2024,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Adenosine; Medicine; Adenosine receptor; Pharmacology; Adenosine A2A receptor; Receptor; Immunology; Internal medicine; Agonist","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002055226,0.0005565072,0.0002946109,0.0002977012,0.0001234534,0.0003667706,0.0004461973,0.0004755297,0.003261319],"category_scores_gemma":[0.0001511595,0.0001326771,0.0003106934,0.0001638628,0.0001612883,0.0002844423,0.000299628,0.0008280145,0.001376811],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002471167,"about_ca_system_score_gemma":0.0003421559,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002702464,"about_ca_topic_score_gemma":0.0004953657,"domain_scores_codex":[0.999933,0.00001025459,0.000003500999,0.00001481514,0.00002091239,0.00001760986],"domain_scores_gemma":[0.9999616,0.000003262039,0.000006678509,0.000002038204,0.000008679712,0.00001770404],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0007941655,0.001033341,0.0005774063,0.001088934,0.0001287176,0.001177804,0.0001011239,0.00310785,0.8159025,0.005479303,0.0134793,0.1571296],"study_design_scores_gemma":[0.002247245,0.0169164,0.004261457,0.0003221256,0.0002840898,0.004599744,0.00008512402,0.01400076,0.7196712,0.002241194,0.235256,0.0001148722],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7727448,0.06073539,0.07994691,0.004408494,0.001448909,0.002151843,0.004774908,0.001376979,0.07241185],"genre_scores_gemma":[0.9051393,0.02580707,0.02466608,0.002385915,0.0002162042,0.0004137756,0.004710004,0.00008698961,0.03657465],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003261319,"threshold_uncertainty_score":0.01091021,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01673330027036038,"score_gpt":0.2919811217501078,"score_spread":0.2752478214797474,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}